3
Clinical Trials associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.) / Active, not recruitingPhase 3 A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 6 Months to 5 Years
The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.
/ Active, not recruitingPhase 3 A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months
The purpose of this study is to evaluate the immunogenicity and safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 to 5 months old.
Clinical Study of Lot-to-Lot Consistency for Group A and C Meningococcal Polysaccharide Conjugate Vaccine
Start Date14 Oct 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Translational Medicine associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Patents (Medical) associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Deals associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)